Search

everythinglearnresearchcommunity

for

Search:↓

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

The document is a detailed medical reference on skin and genetic disorders.

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

The document provides a comprehensive index of medical and surgical topics, including hair removal, hair restoration, and various treatments for injuries and conditions.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

Too much Smad7 can cause serious changes in skin tissues, including problems with hair growth, thymus shrinkage, and eye development issues.

No treatment fully prevents hair loss from chemotherapy yet.

The skin protects the body and is constantly renewed by stem cells; disruptions can lead to cancer.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Mice with human skin protein K8 had more skin problems and cancer.

Disrupting Acvr1b in mice causes severe hair loss and thicker skin.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.